NL-OMON42796已完成不适用
A randomized, double blind, placebo-controlled study on the effect of 3 months treatment with the analgesic tapentadol on conditioned pain modulation (CPM) and pain relief in patients with chronic pain from fibromyalgia - FCAT
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •-Age: 18 * 75 years.
- •- Sex: Either sex.
- •- American Society of Anesthesiologists class 1 and 2 patients, 18 * 75 years; BMI < 40 kg/m2, and ability to give informed consent.
- •Additionally patients need to have a pain score * 5 (on a scale of 0-10) for most of the day and meet the 2010 American College of Rheumatology diagnostic criteria
- •-defects in CPM
排除标准
- •Unable to give written informed consent; medical disease such as pulmonary, renal, liver, cardiac, gastro-intestinal, vascular disease; (iii) allergy to study medication; (iv) history of illicit drug abuse or alcohol abuse; (v) history of psychosis; (vi) epilepsy; (vii) pregnancy and/or lactation; (viii) strong opioids and benzodiazepine use.
研究者
相似试验
进行中（未招募）
不适用
Effect of treatment with the painkiller tapentadol on pain in patients with fibromyalgiaFibromyalgiaEUCTR2015-005258-37-NLMC
已完成
不适用
A randomized, double blind, placebo-controlled study on the effect of 3 months treatment with the analgesic tapentadol on conditioned pain modulation (CPM) and pain relief in patients with chronic low back pailow back pain10028377NL-OMON42741eids Universitair Medisch Centrum40
尚未招募
3 期
A randomized, double blind, placebo-controlled study evaluating efficacy of Topical Aloe Vera Gel for prevention of radiation dermatitis in head and neck cancer patients receiving concurrent chemoradiotherapyearly stage of locally advance stage of head and neck cancerhead and neck cancerTCTR20230707005avamindradhiraj University Research fund130
进行中（未招募）
1 期
Safety and effect of QBW276 in patients with cystic fibrosisMedDRA version: 20.0 Level: PT Classification code 10011762 Term: Cystic fibrosis System Organ Class: 10010331 - Congenital, familial and genetic disordersCystic FibrosisEUCTR2014-004915-35-DEovartis Pharma AG16
已完成
3 期
A clinical trial to evaluate effects of Metabiotics of bacillus subtilis (B-2335) in Healthy SubjectsCTRI/2022/04/041610PRG Pharma Pvt Ltd108